Literature DB >> 26941018

miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.

Mireille Ouimet1, Elizabeth J Hennessy1, Coen van Solingen1, Graeme J Koelwyn1, Maryem A Hussein2, Bhama Ramkhelawon1, Katey J Rayner3, Ryan E Temel4, Ljubica Perisic5, Ulf Hedin5, Lars Maegdefessel6, Michael J Garabedian2, Lesca M Holdt7, Daniel Teupser7, Kathryn J Moore1.   

Abstract

OBJECTIVE: Cholesterol homeostasis is fundamental to human health and is, thus, tightly regulated. MicroRNAs exert potent effects on biological pathways, including cholesterol metabolism, by repressing genes with related functions. We reasoned that this mode of pathway regulation could be exploited to identify novel genes involved in cholesterol homeostasis. APPROACH AND
RESULTS: Here, we identify oxysterol-binding protein-like 6 (OSBPL6) as a novel target of 2 miRNA hubs regulating cholesterol homeostasis: miR-33 and miR-27b. Characterization of OSBPL6 revealed that it is transcriptionally regulated in macrophages and hepatocytes by liver X receptor and in response to cholesterol loading and in mice and nonhuman primates by Western diet feeding. OSBPL6 encodes the OSBPL-related protein 6 (ORP6), which contains dual membrane- and endoplasmic reticulum-targeting motifs. Subcellular localization studies showed that ORP6 is associated with the endolysosomal network and endoplasmic reticulum, suggesting a role for ORP6 in cholesterol trafficking between these compartments. Accordingly, knockdown of OSBPL6 results in aberrant clustering of endosomes and promotes the accumulation of free cholesterol in these structures, resulting in reduced cholesterol esterification at the endoplasmic reticulum. Conversely, ORP6 overexpression enhances cholesterol trafficking and efflux in macrophages and hepatocytes. Moreover, we show that hepatic expression of OSBPL6 is positively correlated with plasma levels of high-density lipoprotein cholesterol in a cohort of 200 healthy individuals, whereas its expression is reduced in human atherosclerotic plaques.
CONCLUSIONS: These studies identify ORP6 as a novel regulator of cholesterol trafficking that is part of the miR-33 and miR-27b target gene networks that contribute to the maintenance of cholesterol homeostasis.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  cholesterol; cholesterol homeostasis; lipids and lipoproteins; macrophages; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26941018      PMCID: PMC4850101          DOI: 10.1161/ATVBAHA.116.307282

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

1.  Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolemia.

Authors:  Jérémie Nsengimana; Nilesh J Samani; Alistair S Hall; Anthony J Balmforth; Massimo Mangino; Nadira Yuldasheva; Azhar Maqbool; Peter Braund; Paul Burton; D Timothy Bishop; Stephen G Ball; Jennifer H Barrett
Journal:  Eur J Hum Genet       Date:  2006-12-06       Impact factor: 4.246

2.  MicroRNA-management of lipoprotein homeostasis.

Authors:  Xinghui Sun; Mark W Feinberg
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 3.  Cholesterol, the central lipid of mammalian cells.

Authors:  Frederick R Maxfield; Gerrit van Meer
Journal:  Curr Opin Cell Biol       Date:  2010-06-02       Impact factor: 8.382

4.  Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.

Authors:  Isabelle Gerin; Laure-Alix Clerbaux; Olivier Haumont; Nicolas Lanthier; Arun K Das; Charles F Burant; Isabelle A Leclercq; Ormond A MacDougald; Guido T Bommer
Journal:  J Biol Chem       Date:  2010-08-22       Impact factor: 5.157

5.  MicroRNAs in metabolism and metabolic diseases.

Authors:  V Rottiers; S H Najafi-Shoushtari; F Kristo; S Gurumurthy; L Zhong; Y Li; D E Cohen; R E Gerszten; N Bardeesy; R Mostoslavsky; A M Näär
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-12

6.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

7.  Subfamily III of mammalian oxysterol-binding protein (OSBP) homologues: the expression and intracellular localization of ORP3, ORP6, and ORP7.

Authors:  Markku Lehto; Jukka Tienari; Sanna Lehtonen; Eero Lehtonen; Vesa M Olkkonen
Journal:  Cell Tissue Res       Date:  2003-10-31       Impact factor: 5.249

Review 8.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

Authors:  Laurent Yvan-Charvet; Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-01       Impact factor: 8.311

9.  miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity.

Authors:  Ryan M Allen; Tyler J Marquart; Carolyn J Albert; Frederick J Suchy; David Q-H Wang; Meenakshisundaram Ananthanarayanan; David A Ford; Angel Baldán
Journal:  EMBO Mol Med       Date:  2012-07-05       Impact factor: 12.137

10.  HDL cholesterol in females in the Framingham Heart Study is linked to a region of chromosome 2q.

Authors:  Kari E North; Lisa J Martin; Tom Dyer; Anthony G Comuzzie; Jeff T Williams
Journal:  BMC Genet       Date:  2003-12-31       Impact factor: 2.797

View more
  28 in total

Review 1.  Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins.

Authors:  Abhishek K Singh; Binod Aryal; Xinbo Zhang; Yuhua Fan; Nathan L Price; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Semin Cell Dev Biol       Date:  2017-12-06       Impact factor: 7.727

2.  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Authors:  Mireille Ouimet; Hasini Ediriweera; Milessa Silva Afonso; Bhama Ramkhelawon; Ragunath Singaravelu; Xianghai Liao; Rachel C Bandler; Karishma Rahman; Edward A Fisher; Katey J Rayner; John P Pezacki; Ira Tabas; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

Review 3.  High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.

Authors:  Yi He; Vishal Kothari; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

Review 4.  Bridging the molecular and biological functions of the oxysterol-binding protein family.

Authors:  Antonietta Pietrangelo; Neale D Ridgway
Journal:  Cell Mol Life Sci       Date:  2018-03-13       Impact factor: 9.261

Review 5.  HDL and Reverse Cholesterol Transport.

Authors:  Mireille Ouimet; Tessa J Barrett; Edward A Fisher
Journal:  Circ Res       Date:  2019-05-10       Impact factor: 17.367

6.  The Adrenal Clock Prevents Aberrant Light-Induced Alterations in Circadian Glucocorticoid Rhythms.

Authors:  William C Engeland; Logan Massman; Shubhendu Mishra; J Marina Yoder; Sining Leng; Emanuele Pignatti; Mary E Piper; Diana L Carlone; David T Breault; Paulo Kofuji
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

Review 7.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

8.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 9.  Regulation of macrophage immunometabolism in atherosclerosis.

Authors:  Graeme J Koelwyn; Emma M Corr; Ebru Erbay; Kathryn J Moore
Journal:  Nat Immunol       Date:  2018-05-18       Impact factor: 25.606

Review 10.  Nonhuman Primates and Translational Research-Cardiovascular Disease.

Authors:  Laura A Cox; Michael Olivier; Kimberly Spradling-Reeves; Genesio M Karere; Anthony G Comuzzie; John L VandeBerg
Journal:  ILAR J       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.